Welcome To Australian Rules Medication Compliance

04-01-2008 | Categories:


medication compliance competition

Contestant in Australian Rules Medication Compliance tournament receives scores


OK, as far as I know, there are no medication compliance tournaments, but, according to Scores help patients keep pace with prescriptions, by Adam Cresswell in The Australian (March 29, 2008),

Patients will be scored on how closely they follow their doctor’s orders in taking their prescribed medications, in a move designed to lift adherence rates and improve outcomes for people with chronic conditions.

The article goes on to point out,

The scores will be expressed as a “mark” out of 100, and will be colour-coded to indicate increasing levels of concern as scores get lower. Pharmacists will be encouraged to help patients whose scores are slipping into the red, by packing multiple medicines into blister packs that make it easier to see which drugs are due to be swallowed at particular times. For more difficult cases, patients may be asked to see their GP for a home medication review, which is designed to simplify a patient’s drug regimen.
However, the scores are not designed to imply fault or blame, and no penalties or sanctions will apply to people with low scores. (Emphasis mine)

The basic mechanisms of the plan are outlined in these excerpts:

The new scheme will work by comparing the time it takes patients to return to a pharmacy to have a repeat script filled, with the time it would have taken them had they taken all the previous doses at the appointed times.
The MedsIndex scheme has been devised by the Pharmacy Guild, which has already run it as a successful four-month pilot, mainly in Victoria and Queensland.
Pharmacy Guild president Kos Sclavos said research showed patients’ adherence to dosing schedules plunged rapidly in line with the number of daily medicines they were supposed to take. Among patients taking one pill per day, compliance was about 80 per cent, but fell to 72 per cent for those taking two pills — and to just 64 per cent among patients taking three pills every day. Sclavos said even an 80 per cent compliance raised concerns, as “drug manufacturers don’t confirm their drugs remain efficacious if you are missing one dose in five”. A score of 90 out of 100 suggested room for improvement, but Sclavos said the Guild would ask pharmacists to consider packing medicines in labelled blister packs for patients with scores below 80. “If it’s 75 or lower, they should be seeing their doctor about a home medicine review,” he said. Sclavos said the 200 patients involved in the pilot — which was run merely to ensure the IT systems worked properly — became obsessed by their scores and did not want to come off the scheme. “We’ve had patients coming back saying ‘Please measure me again’ — that’s how enthusiastic patients have been,” Sclavos said. Aaron D’Souza, a pharmacist in Brisbane’s CBD, helped devise and trial the scheme and described its reception by patients as “absolutely fantastic.” “A typical response (to a low score) is ‘Really? I knew I missed some medicines sometimes, but not that much’,” D’Souza said.


Commentary

I am wholeheartedly in favor of compliance with prescribed healthcare measures, including medications, being monitored - in theory. Simply put, noncompliance will not be recognized, let alone be rectified, unless ongoing, routine monitoring is in in place.

Heck, I think it is even possible that compliance monitoring can be accomplished in practice if sufficient care and planning is invested in the effort.

I do, however, have qualms about the proposal written up in The Australian.

First among them is the notion that “the scores are not designed to imply fault or blame, and no penalties or sanctions will apply to people with low scores.” I’m fully willing to believe that this statement reflects the intent of those responsible for the program.

It does not require much effort, on the other hand, to imagine scenarios in which certain parties would face temptations to change or illicitly abuse this principle.

Not being familiar with systems of Australian healthcare payment or the medico-legal system, I’ll give an example or two based on how the American healthcare system operates.

As healthcare expenses increase, somebody in the government, the insurance industry, or a payer (e.g., an employer) is going to have the epiphany that patients who don’t adhere to prescribed medication dosing cost more than those who do. Clearly it would be not only a cost-saving but also justifiable to reduce the benefits or increase the personal fees paid by this group, members of whom could be identified by an adjustment in the system.

Somewhere else, a lawyer defending a physician accused of malpractice will seek judicial leave to present the patient’s compliance score of 45 as evidence that the treatment failed because of poor adherence rather than the doctor’s error.

And, those justifications may indeed be legitimate. My point is only that there will be pressure to use these scores in ways not currently intended. And once recorded, this compliance rating will be vulnerable to the intrusions of politicians, lawyers, healthcare officials, and others.

My other area of concern is that this important change is predicated on a four month study of 200 patients - “which was run merely to ensure the IT systems worked properly” - and research that “showed patients’ adherence to dosing schedules plunged rapidly in line with the number of daily medicines they were supposed to take.”

While studies tend to show that decreased compliance is coupled with an increased number of doses per day, that research is not unanimous. Nor are the remedies listed, blister packs of medication and simplified drug regimens, both of which are reasonable responses and which are beneficial to some
patients, panaceas for all nonadherence. And, since most physicians try to minimize dosing for all patients, it is difficult to see how that measure will have a dramatic effect.

The enthusiasm demonstrated by some of those 200 patients notwithstanding, one wonders if the novelty of this program may not wilt after a few months with a corresponding decrease in interest by patients and clinicians.

There are other imperfections as well. The compliance formula, which “compar[es] the time it takes patients to return to a pharmacy to have a repeat script filled, with the time it would have taken them had they taken all the previous doses at the appointed times” has several built-in potential flaws, the most significant of which is perhaps that picking up ones prescriptions at the correct times is not synonymous with taking the medications as prescribed. In the US, it is not unusual for a patient to semi-surreptitiously obtain medications from other countries to reduce costs. Doing so would, I assume, bypass the monitoring system.

Perhaps the point of this jeremiad disguised as a post is that monitoring the compliance of all patients in a practice, an insurance group, or a country offers great opportunity to improve healthcare - but not if it addresses only one area of noncompliance with one set of responses, especially since it puts those those patients at some risk of their compliance records being used to make their healthcare more expensive or less accessible.



Related Posts: